Ainos, Inc.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of applicable U.S. securities laws, including statements concerning delivery and payment timing; partner funding and execution; sublicensing, additional licenses and product supply; clinical and regulatory plans; resource efficiencies; and future commercial value. These statements reflect current expectations and are subject to risks and uncertainties, including satisfaction of contractual conditions, counterparty performance and financial resources, completion of qualifying transactions, clinical results, regulatory requirements, manufacturing readiness and execution of the Company’s strategy. Actual results may differ materially.

Historical clinical experience does not guarantee future safety, efficacy, approval or commercial success. No guaranteed commercialization timetable or quantified savings have been established. Potential receipts are not equivalent to recognized revenue; recognition depends on applicable accounting requirements and satisfaction of relevant performance obligations. Additional risks are described in Ainos’ SEC filings. The Company undertakes no obligation to update forward-looking statements except as required by law.